These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 24347663)

  • 1. Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.
    van Deursen VM; Damman K; Voors AA; van der Wal MH; Jaarsma T; van Veldhuisen DJ; Hillege HL
    Circ Heart Fail; 2014 Jan; 7(1):35-42. PubMed ID: 24347663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.
    Elsharawy S; Raslan L; Morsy S; Hassan B; Khalifa N
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):49-54. PubMed ID: 26787566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH; Lewis JR; Wong G; Teo R; Lim EM; Byrnes E; Prince RL
    Am J Nephrol; 2015; 41(2):156-64. PubMed ID: 25824561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
    Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.
    Pronschinske KB; Qiu S; Wu C; Kato TS; Khawaja T; Takayama H; Naka Y; Templeton DL; George I; Farr MA; Mancini DM; Schulze PC
    J Heart Lung Transplant; 2014 Dec; 33(12):1215-22. PubMed ID: 25049066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.
    Fassett RG; Robertson IK; Ball MJ; Geraghty DP; Cardinal JW; Coombes JS
    Nephrol Dial Transplant; 2012 Jan; 27(1):182-9. PubMed ID: 21543653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
    Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
    Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism.
    Kostrubiec M; Łabyk A; Pedowska-Włoszek J; Dzikowska-Diduch O; Wojciechowski A; Garlińska M; Ciurzyński M; Pruszczyk P
    Heart; 2012 Aug; 98(16):1221-8. PubMed ID: 22705926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.
    Liu Y; Li HX; Ying ZW; Guo JJ; Cao CY; Jia W; Yang HR
    Clin Lab; 2016; 62(1-2):155-63. PubMed ID: 27012045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL; Wang ZJ; Yang Q; Yu M; Shen H; Nie B; Han HY; Gao F; Zhou YJ
    Chin Med J (Engl); 2012 Mar; 125(6):1051-6. PubMed ID: 22613530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.
    Papassotiriou GP; Kastritis E; Gkotzamanidou M; Christoulas D; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Roussou M; Margeli A; Papassotiriou I; Dimopoulos MA; Terpos E
    Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):29-35. PubMed ID: 26632077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney function assessed by eGFR, cystatin C and NGAL (neutrophil gelatinase-associated lipocalin) in relation to age in heart allograft recipients.
    Przybylowski P; Malyszko J; Malyszko J
    Med Sci Monit; 2010 Sep; 16(9):CR440-4. PubMed ID: 20802417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C as early biomarkers for early detection of renal failure in patients with hypertension.
    Gharishvandi F; Kazerouni F; Ghanei E; Rahimipour A; Nasiri M
    Iran Biomed J; 2015; 19(2):76-81. PubMed ID: 25864811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure.
    Alvelos M; Lourenço P; Dias C; Amorim M; Rema J; Leite AB; Guimarães JT; Almeida P; Bettencourt P
    Int J Cardiol; 2013 Apr; 165(1):51-5. PubMed ID: 21872946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin (NGAL) in chronic cardiorenal failure is correlated with endogenous erythropoietin levels and decreases in response to low-dose erythropoietin treatment.
    Emans ME; Braam B; Diepenbroek A; van der Putten K; Cramer MJ; Wielders JP; Swinkels DW; Doevendans PA; Gaillard CA
    Kidney Blood Press Res; 2012; 36(1):344-54. PubMed ID: 23235391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
    Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study.
    Haase-Fielitz A; Bellomo R; Devarajan P; Story D; Matalanis G; Dragun D; Haase M
    Crit Care Med; 2009 Feb; 37(2):553-60. PubMed ID: 19114878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.